Professional Documents
Culture Documents
RY
Review
Jan Reynald Shane A. Coquilla, MD, MPH
February 21
2023
OUTLINE
Quick Review on Biochemistry
Simulated Preboard Questions and
Review on Basic Concepts
• NUCLEOTIDES
• NUCLEOTIDE METABOLISM
• LIPIDS
• LIPID METABOLISM
• CHOLESTEROL
• BILE SALTS
• LIPOPROTEIN
ADD A FOOTER 2
QUESTION
ADD A FOOTER 3
QUESTION
ADD A FOOTER 4
NITROGENOUS BASES
• Nitrogen-containing heterocycles
• Purine & Pyrimidine
NITROGENOUS BASES
• RIBONUCLEOSIDE
• D-ribose
• DEOXYRIBONUCLEOSIDE
• 2-deoxy-D-ribose
NUCLEOSIDES
CHM060: BIOMOLECULES
NUCLEOTIDE
• Phosphorylated nucleosides
• Nucleoside + phosphate group
• Phosphate groups
• Usually attached to the 5’ hydroxyl group of sugar
• Nucleoside diphosphate/triphosphate
CHM060: BIOMOLECULES
NUCLEOTIDES
•Functions
• Precursors of nucleic acids
• Participate in metabolic functions
• Energy metabolism
• Protein synthesis
• Regulation of enzyme activity
• Signal transduction
CHM060: BIOMOLECULES
NUCLEOTIDE
CHM060: BIOMOLECULES
CHM060: BIOMOLECULES
Universal Electron Carriers
•ATP is a
building block
of these
CHM060: BIOMOLECULES
Coenzyme A and cylic AMP
•CoA
• Krebs Cycle
• Lipid synthesis and
oxidation
•cAMP
• Acts as a 2nd messenger
activating Potein
Kinase A
CHM060: BIOMOLECULES
QUESTION
ADD A FOOTER 16
QUESTION
ADD A FOOTER 17
QUESTION
Mr. C, a 45 year old male patient, consulted for knee joint swelling. It was revealed that he ate a plateful
of bopis during a drinking spree the night before. An impression of an acute attack of gout was then given:
7. Which of the following is the ultimate and unique product of purine nucleotide degradation in man
contributory to the patient’s joint swelling and pain?
A. Hypoxanthine
B. Urea
C. Uric Acid
D. NH4+
E. Allantoin
ADD A FOOTER 18
QUESTION
Mr. C, a 45 year old male patient, consulted for knee joint swelling. It was revealed that he ate a plateful
of bopis during a drinking spree the night before. An impression of an acute attack of gout was then given:
7. Which of the following is the ultimate and unique product of purine nucleotide degradation in man
contributory to the patient’s joint swelling and pain?
A. Hypoxanthine
B. Urea
C. Uric Acid
D. NH4+
E. Allantoin
ADD A FOOTER 19
QUESTION
Mr. C, a 45 year old male patient, consulted for knee joint swelling. It was revealed that he ate a
plateful of bopis during a drinking spree the night before. An impression of an acute attack of gout
was then given:
8. One of the following mechanism of allopurinol usually prescribed for the treatment of patients
with gout:
• Purine generation
• 2 ways
• De Novo Purine Synthesis
• Salvage Pathway
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
• SYNTHESIS OF PURINE
NUCLEOTIDES
• The purine base is synthesized
on the ribose moiety.
• 5’ phosphoribosyl-1-
pyrophosphate (PRPP)
• formed in the liver
• An activated pentose
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
• SYNTHESIS OF PURINE
NUCLEOTIDES
• Synthesis of 5’-
phosphoribosylamine
• Committed step in purine
nucleotide biosynthesis
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
• SYNTHESIS OF
PURINE
NUCLEOTIDES
• IMP to AMP and GMP
• Two step energy
requiring pathway
NUCLEOTIDE METABOLISM
• SYNTHESIS OF PURINE
NUCLEOTIDES
• IMP to AMP and GMP
• Each product, by feedback inhibition.
regulates its own synthesis from the
IMP branch point as well as inhibits
the initial step in the pathway.
• AMP and GMP can be
phosphorylated to the triphosphate
level.
NUCLEOTIDE METABOLISM
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
• DEGRADATION OF PURINE
NUCLEOTIDES
• Degradation in the small intestine
• Pancreatic enzymes
• Mucosal enzymes
• Nucleosides and free bases
• Formation of Uric ACID
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
• PYRIMIDINE SYNTHESIS
• Ring is synthesized before being attached to
ribose-5-phosphate
• Synthesis of carbamoyl phosphate
• REGULATED STEP
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
• PYRIMIDINE SYNTHESIS
• OMP UMP
• Synthesis of UTP and CTP
• Synthesis of TMP from dUMP
• Thymidylate synthase – uses N5,N10 –
methylene-FH4 as source of methyl
group
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
• PYRIMIDINE
DEGRADATION
• Pyrimidine ring is opened and
degraded to:
• Alanine
• Aminoisobutyrate
• NH4
• CO2
CHM060: BIOMOLECULES
NUCLEOTIDE METABOLISM
CHM060: BIOMOLECULES
QUESTION
14. Which of the following can be absorbed by the
intestine in the absence of micelles?
A. Lipid-soluble vitamins
B. Lysophospholipids
C. Cholesterol
D. Short chain fatty acids
ADD A FOOTER 38
QUESTION
14. Which of the following can be absorbed by the
intestine in the absence of micelles?
A. Lipid-soluble vitamins
B. Lysophospholipids
C. Cholesterol
D. Short chain fatty acids
ADD A FOOTER 39
QUESTION
71. Which of the following are the end products of
digestion of triacylglycerol by pancreatic lipase prior to re-
esterification inside intestinal cells?
A. 3 free fatty acids and glycerol
B. 2-monoacylglycerol and 2 free fatty acids
C. 3-monoacylglycerol and 1 fatty acid
D. glycerol -3 phosphate and 3 fatty acids
ADD A FOOTER 40
QUESTION
71. Which of the following are the end products of
digestion of triacylglycerol by pancreatic lipase prior to re-
esterification inside intestinal cells?
A. 3 free fatty acids and glycerol
B. 2-monoacylglycerol and 2 free fatty acids
C. 3-monoacylglycerol and 1 fatty acid
D. glycerol -3 phosphate and 3 fatty acids
ADD A FOOTER 41
QUESTION
81. The end product of fatty acid synthesis de
novo prior to further elongation is:
A. stearic acid
B. lignoneric acid
C. palmitic acid
D. oleic acid
ADD A FOOTER 42
QUESTION
81. The end product of fatty acid synthesis de
novo prior to further elongation is:
A. stearic acid
B. lignoneric acid
C. palmitic acid
D. oleic acid
ADD A FOOTER 43
QUESTION
82. Which of the following is true of beta
oxidation of fatty acids?
A. occurs primarily in the cytosol and endoplasmic reticulum
B. carnitine transports fatty acyl-CoA from the cytosol into the
mitochondrial matrix where oxidation takes place
C. Acyl Carrier Protein (ACP) is required for the attachment of fatty acyl-
CoA
D. generates principally propionyl-CoA as final products for even number
fatty acids
ADD A FOOTER 44
QUESTION
82. Which of the following is true of beta
oxidation of fatty acids?
A. occurs primarily in the cytosol and endoplasmic reticulum
B. carnitine transports fatty acyl-CoA from the cytosol into the
mitochondrial matrix where oxidation takes place
C. Acyl Carrier Protein (ACP) is required for the attachment of fatty acyl-
CoA
D. generates principally propionyl-CoA as final products for even number
fatty acids
ADD A FOOTER 45
QUESTION
83. Ketogenesis in the liver occurs during this
metabolic condition:
A. Lignoceric Acid
B. Arachidonic Acid
C. Docosahexaenoic acid
D. Stearic Acid
ADD A FOOTER 48
QUESTION
59. Prostaglandins are derived from:
A. Lignoceric Acid
B. Arachidonic Acid
C. Docosahexaenoic acid
D. Stearic Acid
ADD A FOOTER 49
LIPIDS
CHM060: BIOMOLECULES
LIPID CLASSES
• FATTY ACID
• Building block • 2 properties
• TRIACYLGLYCEROLS • Insoluble in water
• Storage form
• WAXES • Soluble in nonpolar
• Protection solvents such as ether and
• PHOSPHOLIPIDS chloroform
• Membranes
• SPHINGOLIPIDS
• Membranes
• STEROIDS
• Membranes and hormones
CHM060: BIOMOLECULES
FATTY ACIDS
CHM060: BIOMOLECULES
CHM060: BIOMOLECULES
ω Fatty Acids are anti-inflammatory and have health
benefits
• Long chain ω3 FA
• α-linolenic acid (ALA) – plant oils
• Eicosapentaenoic acid (EPA) – fish oils
• Docosahexaenoic acid (DHA) – fish and algal oils
• Potential use for chronic inflammatory diseases
• Diets rich in ω3 are beneficial for:
• Cardiovascular diseases
• Cancer
• Rheumatoid arthritis
• Alzheimer’s disease
CHM060: BIOMOLECULES
CHM060: BIOMOLECULES
CHM060: BIOMOLECULES
CHM060: BIOMOLECULES
ARACHIDONIC ACID
CHM060: BIOMOLECULES
CHM060: BIOMOLECULES
CHM060: BIOMOLECULES
STEROIDS
CHM060: BIOMOLECULES
CHOLESTEROL
• Best known for its
association with heart
disease
• Widely distributed in all
cells particularly in
nervous tissue
• Major constituent of the
plasma membrane
• Essential Role:
• Precursor for steroids
CHM060: BIOMOLECULES
ERGOSTEROL
CHM060: BIOMOLECULES
FATTY ACID METABOLISM
• Degradation
• Triacylglycerols and
fatty acids
• Ketone Bodies
• Biosynthesis
• Fatty acids
CHM060: BIOMOLECULES
ABSORPTION OF LIPIDS
CHM060: BIOMOLECULES
LIPOLYSIS
• Adipose stores TAGs
• In fasting, exercise and stress
• FAs needed as fuel lipolysis
• TAG Lipolysis for FAs to be used as fuel
• Activated by glucagon and epinephrine
• FAs are transported in the blood stream
• Albumin – carrier protein in the blood
• HEART and MUSCLE – primary users of FAs
CHM060: BIOMOLECULES
FATTY ACID ACTIVATION
CHM060: BIOMOLECULES
CARNITINE SHUTTLE
Carnitine
acyltrans
ferase I
• MATRIX
• ACYL CARNITINE conversion to Acyl-CoA by
CAT II
CHM060: BIOMOLECULES
FATTY ACID OXIDATION
• FA
• broken down by oxidation to acetyl-CoA
• Breakdown of FA
• Each step involves Acyl-CoA derivatives
• Catalyzed by separate enzymes
• Requires NAD+ and FAD
• Generates ATP
• Aerobic process = REQUIRES OXYGEN
CHM060: BIOMOLECULES
FATTY ACID OXIDATION
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY ACID
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
• Four steps
1. Acyl-CoA dehydrogenase
(dehydrogenation)
• Reduction of FAD, C=C formation
2. Enoyl-CoA hydratase (hydration)
3. ß-hydroxyacyl-CoA
dehydrogenase (oxidation)
• Reduction of NAD+
4. Thiolase: production of acetyl-
CoA (thiolysis)
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
• FOR SATURATED FA
• 1 cycle
• 1 NADH
• 1 FADH2
• 1 Acetyl-CoA
• Last cycle would produce additional 1 acetyl-CoA
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
• FOR UNSATURATED FA
• For 1 double bond = loss of 1 FADH2
• First step of ß-oxidation is skipped
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
• PRODUCES LARGE AMOUNTS OF ATP
• C16 – palmitate
• 7 cycles
• Per cycle
• 1 mol NADH = 2.5 mol ATP from ETC
• 1 mol of FADH2 = 1.5 mol ATP from ETC
4 mol of ATP per cycle
• From electron carriers = 7 cycles x 4 mol of ATP = 28 mol ATP
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
CHM060: BIOMOLECULES
ß-OXIDATION OF FATTY
CHM060: BIOMOLECULES
FATES OF ACETYL-COA
CHM060: BIOMOLECULES
KETOGENESIS
CHM060: BIOMOLECULES
KETOGENESIS
CHM060: BIOMOLECULES
KETONE BODIES SERVE AS A FUEL FOR
EXTRAHEPATIC TISSUES
CHM060: BIOMOLECULES
KETONE BODIES SERVE AS A FUEL FOR
EXTRAHEPATIC TISSUES
CHM060: BIOMOLECULES
KETONE BODIES IN DIABETES
• Diabetic Ketoacidosis
CHM060: BIOMOLECULES
FATTY ACID SYNTHESIS
CHM060: BIOMOLECULES
FATTY ACID SYNTHESIS
CHM060: BIOMOLECULES
FATTY ACID SYNTHESIS
• Immediate
substrate: AcCoA
• Mn2+, NADPH,
ATP, bioitin
• End Product: Free
palmitate
CHM060: BIOMOLECULES
FATTY ACID SYNTHESIS
• Acetyl-CoA Sources
• GLUCOSE
• Glycolysis and PDH
• AMINO ACIDS – all 20 can be converted to fat
• Leu, Ile, Trp, Lys, Phe, Tyr AcCoA
• Ala, Cys, Gly, Ser pyruvate AcCoA
• Asn, Asp, Met, Val, Arg, Glu, Gln, His, Pro
CAC oxaloacetate pyruvate AcCoA
CHM060: BIOMOLECULES
FATTY ACID SYNTHESIS
• NADPH Source
• Pentose Phosphate Pathway
• Shunt of glycolysis
• Allows for the production of ribose for
nucleic acids
CHM060: BIOMOLECULES
ACETYL CoA Activation
• MOST Acetyl CoA must be activated
• One will remain inactivated per FA
formed
• Conversion to malonyl CoA
• Catalyzed by Acetyl CoA carboxylase
• Multienzyme protein
• Contains:
• Biotin
• Biotin carboxylase
• Biotin carboxyl carrier protein (BCP)
• Carboxyl transferase
CHM060: BIOMOLECULES
ACETYL CoA Activation
• Conversion to
malonyl CoA
• STEP 1:
carboxylation of biotin
involving ATP
• STEP 2: transfer of
carboxyl group to
AcCoa to form
malonyl CoA
CHM060: BIOMOLECULES
FATTY ACID SYNTHESIS FROM MALONYL
CoA
• FATTY ACID SYNTHASE
ENZYME COMPLEX
• Multienzyme polypeptide
complex
• Homodimer of 2 polypeptide
chains
• Works in conjunction with
acyl carrier protein (ACP)
• Serve a similar function to CoA
• Contains pantothenic acid (Vit
B5)
CHM060: BIOMOLECULES
CHM060: BIOMOLECULES
QUESTION
For items 12-13: Mr. K is a male patient who complained of nape pains and headache, with a BP of
160/100
12. Lipid profile was determined which revealed elevated LDL cholesterol. This lipoprotein:
ADD A FOOTER 96
QUESTION
For items 12-13: Mr. K is a male patient who complained of nape pains and headache, with a BP of
160/100
12. Lipid profile was determined which revealed elevated LDL cholesterol. This lipoprotein:
ADD A FOOTER 98
QUESTION
For items 12-13: Mr. K is a male patient who complained of nape pains and headache, with a BP of
160/100
13. The hypercholesterolemia which could be seen in this patient could be trated with an inhibitor of
the enzyme which catalyzes this rate limiting step of cholesterol biosynthesis:
A. Cholesterol will increase the uptake of low density lipoproteins from the
circulation.
B. Upregulation of LDL receptors on the cell surface results in the activation of
HMG CoA reductase
C. Insulin activates HMG-CoA reductase by dephosphorylation of the enzyme.
D. Cholesterol, as a product of de novo synthesis, increases HMG-CoA
reductase synthesis and activity
A. Cholesterol will increase the uptake of low density lipoproteins from the
circulation.
B. Upregulation of LDL receptors on the cell surface results in the activation of
HMG CoA reductase
C. Insulin activates HMG-CoA reductase by dephosphorylation of the enzyme.
D. Cholesterol, as a product of de novo synthesis, increases HMG-CoA reductase
synthesis and activity
CHM060: BIOMOLECULES
CHOLESTEROL
• CHOLESTEROL RING
• Cannot be degraed
• Forms bile salts for
exceretion
CHM060: BIOMOLECULES
BILE SALTS
• PRIMARY BILE ACIDS
• Cholic acid
• Chenodeoxycholic acid
• Synthesized in the liver
• 7α-hydroxylase – regulatory enzyme
• Enter bile as glycine or taurine conjugates
• Further metabolized by intestinal bacteria
forming secondary bile acids
• SECONDARY BILE ACIDS
• Deoxycholic acid
• Lithocholic acid
CHM060: BIOMOLECULES
BILE SALTS
• FATE OF BILE SALTS
• Primary
• Liver secreted as bile gallbladder
intestine aid in lipid digestion
• Secondary
• …intestine primary bile deconjugated
secondary bile salts
• RESORBED in the ileum and retured to
the liver via the ENTEROHEPATIC
CIRCULATION
• 95% recycled
• 5% feces
CHM060: BIOMOLECULES
BLOOD LIPOPROTEINS
• Lipoproteins – serve to transport water insoluble TAGs and
cholesterol
• Composition
• Chylomicrons
• are the least dense of the blood lipoproteins because they have the most
triacylglycerol and the least protein.
• Deliver dietary lipids
• VLDL
• is more dense than chylomicrons but still has a high content of
triacylglycerol.
• Deliver endogenous lipids
CHM060: BIOMOLECULES
BLOOD LIPOPROTEINS
• Lipoproteins – serve to transport water insoluble TAGs and
cholesterol
• Composition
• LDL
• has less triacylglycerol and more protein
• the highest content of cholesterol and its esters.
• Deliver cholesterol to cells
• HDL
• is the most dense lipoprotein.
• lowest triacylglycerol and the highest protein content
• Reverse cholesterol transport
CHM060: BIOMOLECULES
DISORDERS OF PLASMA LIPOPROTEINS
•HYPOLIPOPROTEINEMIA
• Abetalipoproteinemia
• No chylomicrons, VLDL, or LDL are formed
because of defect in the loading of apo B with lipid.
• Rare
• blood acylglycerols low
• intestine and liver accumulate acylglycerols
• Intestinal malabsorption
• Early death avoidable by administration of large
doses of fat-soluble vitamins, particularly vitamin E.
CHM060: BIOMOLECULES
DISORDERS OF PLASMA LIPOPROTEINS
• HYPOLIPOPROTEINEMIA
• Low or near absence of HDL
• Familial alpha-lipoprotein deficiency
• Tangier disease
• Fish-eye disease
• Apo-A-I deficiencies
• Tendency toward hypertriacylglycerolemia as a result of absence
of apo C-ll, causing inactive LPL
• Low LDL levels. Atherosclerosis in the elderly.
CHM060: BIOMOLECULES
DISORDERS OF PLASMA LIPOPROTEINS
•HYPERLIPOPROTEINEMIA
• Familial lipoprotein lipase deficiency (type I)
• to deficiency of LPL, abnormal LPL, or apo C-ll
deficiency causing inactive LPL.
• Familial hypercholesterolemia (type IIa)
• Defective LDL receptors or mutation in ligand
region of apo B-100.
CHM060: BIOMOLECULES
DISORDERS OF PLASMA LIPOPROTEINS
•HYPERLIPOPROTEINEMIA
• Familial type III hyperlipoproteinemia (broad
beta disease, remnant removal disease,
familial dysbetalipoproteinemia)
• Deficiency in remnant clearance by the liver
is due to abnormality in apo E.
• Familial hypertriacylglycerolemia (type IV)
• Overproduction of VLDL often associated
with glucose intolerance and
hyperinsulinemia.
CHM060: BIOMOLECULES
THANK YOU!
Good luck
Study well!